Could a painkiller help treat alcoholism? scientists investigate

NCT ID NCT06029296

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a single dose of diclofenac, a common pain reliever, can change a specific brain chemical in people with alcohol use disorder. Twelve adults with mild to severe alcohol use disorder will receive either diclofenac or a placebo in a double-blind fashion. The goal is to see if diclofenac increases kynurenic acid levels, which may help understand how the brain works in addiction. This is an early-stage study focused on learning, not treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Maryland Psychiatric Research Center (MPRC) Treatment Research Program (TRP)

    Catonsville, Maryland, 21228, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.